Lanxess shares fell 5% in trading following a research note from BNP Paribas that highlighted concerns over weak capacity utilization and potential risks to the company's earnings.
The equity decline reflects market caution regarding the specialty chemical maker's operational outlook amid subdued demand and pressure on production efficiency.
